Concepedia

Paul Richards

PR

36

Publications

2K

Citations

25

H-Index

1968

Active since

Affiliations

Tennessee Oncology(Current)

University of Sheffield

Mountain Blue Cancer Care Center

Texas Oncology

Sheffield Hallam University

Paul Richards is an author at Tennessee Oncology specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

1968–2023

36

Publications

36

Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer

Joyce O’Shaughnessy, Lee Schwartzberg, Michael Danso et al. · Journal of Clinical Oncology · 2014 · 299 citations · Full text

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 263 citations

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey et al. · Blood · 2000 · 248 citations

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul et al. · Clinical Breast Cancer · 2011 · 117 citations · Full text

, , +8

Gemcitabine, Carboplatin, and Paclitaxel for Patients With Carcinoma of Unknown Primary Site: A Minnie Pearl Cancer Research Network Study

F. Anthony Greco, Howard A. Burris, Sharlene Litchy et al. · Journal of Clinical Oncology · 2002 · 111 citations

Rows per page

1–5 of 36